As of 2025-07-11, the Intrinsic Value of Inspire Medical Systems Inc (INSP) is 78.36 USD. This INSP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 139.25 USD, the upside of Inspire Medical Systems Inc is -43.70%.
The range of the Intrinsic Value is 51.41 - 178.79 USD
Based on its market price of 139.25 USD and our intrinsic valuation, Inspire Medical Systems Inc (INSP) is overvalued by 43.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 51.41 - 178.79 | 78.36 | -43.7% |
| DCF (Growth 10y) | 128.47 - 448.86 | 196.42 | 41.1% |
| DCF (EBITDA 5y) | 79.83 - 131.31 | 94.64 | -32.0% |
| DCF (EBITDA 10y) | 136.15 - 225.55 | 162.81 | 16.9% |
| Fair Value | 56.38 - 56.38 | 56.38 | -59.51% |
| P/E | 125.78 - 139.01 | 132.72 | -4.7% |
| EV/EBITDA | 32.49 - 94.21 | 48.99 | -64.8% |
| EPV | (12.30) - (15.05) | (13.67) | -109.8% |
| DDM - Stable | 21.35 - 69.28 | 45.31 | -67.5% |
| DDM - Multi | 60.80 - 155.62 | 87.71 | -37.0% |
| Market Cap (mil) | 4,106.48 |
| Beta | 0.49 |
| Outstanding shares (mil) | 29.49 |
| Enterprise Value (mil) | 4,052.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.16% |
| Cost of Debt | 4.48% |
| WACC | 6.77% |